Dr. Howard Bauchner, editor-in-chief of JAMA, comments on new trends in evidence-based medicine. He notes that randomized controlled studies aren’t always king, even though they’re the most common. Patients want more of a say in the type of treatment they receive, particularly for certain types of cancer and end-of-life care. Dr. Bauchner provides insight on these issues and more.